Evidence map›Paper›PMID 32984339›Full record

ArticleFrontiers in cell and developmental biology2020

Repurposing Fragile X Drugs to Inhibit SARS-CoV-2 Viral Reproduction.

Cara J Westmark, Maki Kiso, Peter Halfmann, Pamela R Westmark, Yoshihiro Kawaoka

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cell and developmental biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Cara J WestmarkDepartment of Neurology, University of Wisconsin-Madison, Madison, WI, United States.
Maki KisoDivision of Virology, Department of Microbiology and Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Peter HalfmannDepartment of Pathobiological Sciences, School of Veterinary Medicine, Influenza Research Institute, University of Wisconsin-Madison, Madison, WI, United States.
Pamela R WestmarkDepartment of Neurology, University of Wisconsin-Madison, Madison, WI, United States.
Yoshihiro KawaokaDivision of Virology, Department of Microbiology and Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
University of Wisconsin–Madison · USThe University of Tokyo · JP

Funding

Does Soy Infant Formula Exacerbate Seizures in Fragile X?R03HD097067 · NICHD · UNIVERSITY OF WISCONSIN-MADISON · PI WESTMARK, CARA JEAN · 2018 to 2019
$153k
NIAID NIH HHS HHSN272201400008CNICHD NIH HHS R03 HD097067
6 · The paper itself

Abstract

The COVID-19 pandemic is a global health crisis that requires the application of interdisciplinary research to address numerous knowledge gaps including molecular strategies to prevent viral reproduction in affected individuals. In response to the Frontiers Research Topic, "

Indexed as

coronavirusCOVID-19fragile X mental retardation proteinmetabotropic glutamate receptor 5protein synthesis

Identifiers

PMID32984339
PMCPMC7479061
OpenAlexW3081341979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.